User contributions
For
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 09:14, 25 March 2018 (diff | hist) . . (+184) . . Valuable threads on the ALSTDI forum
- 07:52, 25 March 2018 (diff | hist) . . (+177) . . Valuable threads on the ALSTDI forum
- 07:45, 25 March 2018 (diff | hist) . . (+102) . . Valuable threads on the ALSTDI forum
- 07:36, 25 March 2018 (diff | hist) . . (+135) . . Valuable threads on the ALSTDI forum
- 07:19, 25 March 2018 (diff | hist) . . (+180) . . N Valuable threads on the ALSTDI forum (Created page with "Here, links are collected to especially valuable discussion threads on the ALSTDI forum. [https://www.als.net/forum/yaf_postst48203_als-theories-summary.aspx ALS Theories Sum...")
- 06:49, 25 March 2018 (diff | hist) . . (+8) . . Main Page (current)
- 06:43, 25 March 2018 (diff | hist) . . (+35) . . Main Page
- 09:46, 28 February 2018 (diff | hist) . . (-2) . . Key molecular pathways in ALS (current)
- 09:44, 28 February 2018 (diff | hist) . . (-2) . . Key molecular pathways in ALS
- 09:39, 28 February 2018 (diff | hist) . . (+3) . . Key molecular pathways in ALS
- 09:36, 28 February 2018 (diff | hist) . . (+10) . . Key molecular pathways in ALS
- 10:04, 26 February 2018 (diff | hist) . . (+1,244) . . Mitochondrial dysfunction (current)
- 19:00, 25 February 2018 (diff | hist) . . (-1) . . NAD depletion (current)
- 18:49, 25 February 2018 (diff | hist) . . (+1) . . NAD depletion
- 18:48, 25 February 2018 (diff | hist) . . (+6) . . NAD depletion
- 18:45, 25 February 2018 (diff | hist) . . (+45) . . NAD depletion
- 18:38, 25 February 2018 (diff | hist) . . (+1,257) . . N NAD depletion (Created page with "Key concepts in ALS ''NAD+ depletion is a common phenomenon in neurodegenerative pathologies. Excitotoxicity occurs in multiple neurologic disorders and NAD+ was shown t...")
- 18:28, 25 February 2018 (diff | hist) . . (+19) . . Key concepts in ALS
- 08:08, 1 February 2018 (diff | hist) . . (+252) . . Information on nutritional supplements people with ALS have been taking
- 12:34, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:27, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:23, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:16, 31 January 2018 (diff | hist) . . (+126) . . Information on nutritional supplements people with ALS have been taking
- 11:55, 31 January 2018 (diff | hist) . . (+64) . . Information on nutritional supplements people with ALS have been taking
- 09:24, 31 January 2018 (diff | hist) . . (+64) . . Information on nutritional supplements people with ALS have been taking
- 07:05, 31 January 2018 (diff | hist) . . (+13) . . Information on nutritional supplements people with ALS have been taking
- 14:38, 28 January 2018 (diff | hist) . . (+1,246) . . Stress granules (current)
- 16:41, 22 January 2018 (diff | hist) . . (+12) . . Uric acid (current)
- 16:32, 22 January 2018 (diff | hist) . . (+1,250) . . N Uric acid (Created page with "Key concepts in ALS ''The pathogenic mechanism of ALS remains unclear. However, increasing evidence has indicated that uric acid (UA) may play a protective role in the pa...")
- 16:27, 22 January 2018 (diff | hist) . . (+37) . . Lab abnormalities (current)
- 11:21, 12 January 2018 (diff | hist) . . (0) . . DMAE (current)
- 11:20, 12 January 2018 (diff | hist) . . (-3,281) . . DMAE
- 08:29, 12 January 2018 (diff | hist) . . (+6) . . Iron metabolism anomalies (current)
- 08:27, 12 January 2018 (diff | hist) . . (+1,842) . . Iron metabolism anomalies
- 06:59, 12 January 2018 (diff | hist) . . (+1,000) . . Autophagy (current)
- 17:50, 13 November 2017 (diff | hist) . . (+1,840) . . MMP-9
- 16:30, 13 November 2017 (diff | hist) . . (+1,747) . . MMP-9
- 16:23, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:20, 13 November 2017 (diff | hist) . . (+1,210) . . MMP-9
- 16:12, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:10, 13 November 2017 (diff | hist) . . (+1,106) . . MMP-9
- 16:04, 13 November 2017 (diff | hist) . . (+1,267) . . MMP-9
- 15:49, 13 November 2017 (diff | hist) . . (+1,813) . . N MMP-9 (Created page with "Key concepts in ALS == Inhibition == ''Ischemic stroke is a leading cause of disability worldwide. In cerebral ischemia there is an enhanced expression of matrix metallo...")
- 14:55, 13 November 2017 (diff | hist) . . (+24) . . Sulforaphane
- 10:23, 13 November 2017 (diff | hist) . . (+40) . . Plan for an Integral Clinical Trial
- 10:17, 13 November 2017 (diff | hist) . . (+118) . . Plan for an Integral Clinical Trial
- 10:08, 13 November 2017 (diff | hist) . . (+138) . . Plan for an Integral Clinical Trial
- 10:01, 13 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:19, 12 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:15, 12 November 2017 (diff | hist) . . (+20) . . Sulforaphane
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)